Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2007HaematologicaOpen Access

Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor   gene

View Full Paper
Ask AI
Bookmark
Share

Authors

CWChristoph WalzLMU KlinikumGMGeorgia MetzgerothHeidelberg UniversityCHClaudia HaferlachMunich Leukemia Laboratory (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Walz et al. (2007) studied this question.

synapsesocial.com/papers/6a847faad7bfb55d3573167chttps://doi.org/10.3324/haematol.10980
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia2005 · 282 citations
  2. 2p53-Binding Protein 1 Is Fused to the Platelet-Derived Growth Factor Receptor β in a Patient with a t(5;15)(q33;q22) and an Imatinib-Responsive Eosinophilic Myeloproliferative Disorder2004 · 72 citations
  3. 3Activation/Division of Lymphocytes Results in Increased Levels of Cytoplasmic Activation/Proliferation-Associated Protein-1: Prototype of a New Family of Proteins2004 · 86 citations
  4. 4Tyrosine Kinases as Targets for Cancer Therapy2005 · 1,389 citations
  5. 5<i>AF5q31</i> , a newly identified <i>AF4</i> -related gene, is fused to <i>MLL</i> in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)1999 · 121 citations